Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MARC-2: Everolimus in mRCC
NCT01266837Phase 4Completed
- Sponsor
- iOMEDICO
- Start
- Mar 2011
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in metastatic renal cell carcinoma (mRCC), sponsored by iOMEDICO. Started Mar 2011; status: completed.
02
Drugs
everolimus
03
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on NCT01266837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01266837.